Constitutive STAT3-activation in Sezary syndrome:: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells

Constitutive STAT3-activation in Sezary syndrome:: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells
复制标题

DOI:
10.1038/sj.leu.2402093
复制
发表时间:
2001-05-01
期刊:
影响因子:
11.4
通讯作者:
Odum, N
Odum, N
中科院分区:
医学1区
文献类型:
--
作者:
Eriksen, KW;Kaltoft, K;Odum, N

文献摘要

被引文献

相似文献

白细胞介素-2(IL-2)是一种生长因子,其在与高亲和力受体(IL-2 R α β γ)结合后触发T细胞中的有丝分裂。IL-2 Ra表达限于最近遇到抗原的T细胞,并且在健康个体中,大多数(> 95%)外周T细胞是IL-2 Ra阴性的。IL-2 Ra的异常表达最近已被描述在皮肤T细胞淋巴瘤(CTCL)。在这里,我们研究了IL-2 R α表达和STATs的调节肿瘤细胞系从外周血中获得的患者与Sezary综合征(SS),CTCL的白血病变异。我们证明:(1)状态(已知调节IL-PR(U转录)的转录因子在SS肿瘤细胞中是组成型酪氨酸磷酸化的,但在非恶性T细胞中不是;(2)STATE与IL-2 R α基因启动子中的STAT结合序列组成型结合;(3)Janus激酶抑制剂,酪氨酸磷酸盐AG 490,平行地抑制STATE激活、STATE DNA结合和IL-2 R α mRNA和蛋白质表达;(4)Tyrphostine AG 490抑制IL-2驱动的SS肿瘤细胞的有丝分裂并触发凋亡。总之,我们提供了SS肿瘤细胞中组成性状态激活的第一个例子。此外,我们的研究结果表明,STATE激活可能在恶性SS细胞的组成性IL-2 R α表达、存活和生长中起重要作用。
Interleukin-2 (IL-2) is a growth factor which upon binding to high-affinity receptors (IL-2R alpha beta gamma) triggers mitogenesis in T cells. IL-2R alpha expression is restricted to T cells which have recently encountered antigen, and in healthy individuals the majority (> 95%) of peripheral T cells are IL-2Ra negative. An aberrant expression of IL-2Ra has recently been described in cutaneous T-cell lymphoma (CTCL). Here, we study the regulation of IL-2R alpha expression and STATs in a tumor cell line obtained from peripheral blood from a patient with Sezary syndrome (SS), a leukemic variant of CTCL. We show that (1) STATE (a transcription factor known to regulate IL-PR(U transcription) is constitutively tyrosine-phosphorylated in SS tumor cells, but not in non-malignant T cells; (2) STATE binds constitutively to a STAT-binding sequence in the promotor of the IL-2R alpha gene; (3) the Janus kinase inhibitor, tyrphostine AG490, inhibits STATE activation, STATE DNA binding, and IL-2R alpha mRNA and protein expression in parallel; and (4) tyrphostine AG490 inhibits IL-2 driven mitogenesis and triggers apoptosis in SS tumor cells. In conclusion, we provide the first example of a constitutive STATE activation in SS tumor cells. Moreover, our findings suggest that STATE activation might play an important role in the constitutive IL-2R alpha expression, survival, and growth of malignant SS cells.